ZD 4007
Latest Information Update: 08 Feb 2008
At a glance
- Originator AstraZeneca
- Class Bronchodilators
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 08 Feb 2008 Discontinued - Preclinical for Chronic obstructive pulmonary disease in United Kingdom (unspecified route)
- 27 Jan 2000 Preclinical development for Chronic obstructive pulmonary disease in United Kingdom (unspecified route)